Artivion (AORT) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.64% |
| Dec 31, 2025 | 21.99% |
| Sep 30, 2025 | 33.66% |
| Jun 30, 2025 | 18.78% |
| Mar 31, 2025 | 40.31% |
| Dec 31, 2024 | -12.14% |
| Sep 30, 2024 | -76.39% |
| Jun 30, 2024 | -22.41% |
| Mar 31, 2024 | 93.84% |
| Dec 31, 2023 | 5.72% |
| Sep 30, 2023 | -52.55% |
| Jun 30, 2023 | -76.16% |
| Mar 31, 2023 | -28.55% |
| Dec 31, 2022 | 17.42% |
| Sep 30, 2022 | -65.32% |
| Jun 30, 2022 | -27.33% |
| Mar 31, 2022 | -28.65% |
| Dec 31, 2021 | -41.07% |
| Sep 30, 2021 | 28.73% |
| Jun 30, 2021 | -23.97% |
| Mar 31, 2021 | -26.47% |
| Dec 31, 2020 | -2.44% |
| Sep 30, 2020 | -27.26% |
| Jun 30, 2020 | -49.02% |
| Mar 31, 2020 | -89.33% |
| Dec 31, 2019 | -48.55% |
| Sep 30, 2019 | -15.52% |
| Jun 30, 2019 | 5.56% |
| Mar 31, 2019 | -17.92% |
| Dec 31, 2018 | -20.78% |
| Sep 30, 2018 | -13.16% |
| Jun 30, 2018 | -33.86% |
| Mar 31, 2018 | -30.32% |
| Dec 31, 2017 | 0.58% |
| Sep 30, 2017 | -2.94% |
| Jun 30, 2017 | -1.05% |
| Mar 31, 2017 | 17.54% |
| Dec 31, 2016 | 24.60% |
| Sep 30, 2016 | 8.19% |
| Jun 30, 2016 | 5.22% |
| Mar 31, 2016 | 8.81% |
| Dec 31, 2015 | -57.98% |
| Sep 30, 2015 | 22.04% |
| Jun 30, 2015 | -16.78% |